22 May 2013
Keywords: fda, panel, rejects, daunoxome, nda, advisory, committee
Article | 28 June 1993
An advisory committee to the US Food and Drug Administration has
rejected Phase II data submitted by Vestar in support ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 June 1993
5 July 1993
21 June 1993
© 2013 thepharmaletter.com